| Primary |
| Migraine |
31.3% |
| Headache |
17.9% |
| Product Used For Unknown Indication |
16.4% |
| Nasopharyngitis |
6.0% |
| Orthostatic Hypotension |
4.5% |
| Prolonged Pregnancy |
4.5% |
| Anaesthesia |
3.0% |
| Drug Use For Unknown Indication |
3.0% |
| Status Migrainosus |
3.0% |
| Toothache |
3.0% |
| Cluster Headache |
1.5% |
| Depression |
1.5% |
| Hiv Infection |
1.5% |
| Hypotension |
1.5% |
| Major Depression |
1.5% |
|
| Medication Error |
10.3% |
| Drug Abuse |
6.9% |
| Overdose |
6.9% |
| Paraesthesia |
6.9% |
| Serotonin Syndrome |
6.9% |
| Suicide Attempt |
6.9% |
| Tongue Biting |
6.9% |
| Weight Decreased |
6.9% |
| Asthma |
3.4% |
| Cardiac Valve Disease |
3.4% |
| Depressed Level Of Consciousness |
3.4% |
| Diplopia |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Drug Withdrawal Syndrome |
3.4% |
| Embolism |
3.4% |
| Headache |
3.4% |
| Hepatic Failure |
3.4% |
| Injection Site Reaction |
3.4% |
| Intracranial Pressure Increased |
3.4% |
| Major Depression |
3.4% |
|
| Secondary |
| Migraine |
20.7% |
| Drug Use For Unknown Indication |
13.0% |
| Headache |
12.0% |
| Depression |
6.5% |
| Foetal Exposure During Pregnancy |
6.5% |
| Anxiety |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Breast Cancer Female |
4.3% |
| Medication Error |
4.3% |
| Insomnia |
3.3% |
| Abdominal Distension |
2.2% |
| Breast Cancer |
2.2% |
| Essential Hypertension |
2.2% |
| Hypertension |
2.2% |
| Nausea |
2.2% |
| Pain |
2.2% |
| Urticaria Chronic |
2.2% |
| Abdominal Pain Upper |
1.1% |
| Acne |
1.1% |
| Analgesia |
1.1% |
|
| Hepatitis Cholestatic |
8.3% |
| Interstitial Lung Disease |
8.3% |
| Premature Baby |
8.3% |
| Vomiting |
8.3% |
| Adverse Event |
4.2% |
| Agitation |
4.2% |
| Drug Hypersensitivity |
4.2% |
| Headache |
4.2% |
| Hyponatraemia |
4.2% |
| Hypothyroidism |
4.2% |
| Maternal Drugs Affecting Foetus |
4.2% |
| Myocardial Infarction |
4.2% |
| Myopathy |
4.2% |
| Osteonecrosis |
4.2% |
| Osteopenia |
4.2% |
| Overdose |
4.2% |
| Pericardial Effusion |
4.2% |
| Premature Labour |
4.2% |
| Psychomotor Retardation |
4.2% |
| Pyelocaliectasis |
4.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.2% |
| Migraine |
13.7% |
| Product Used For Unknown Indication |
10.5% |
| Depression |
4.0% |
| Epilepsy |
4.0% |
| Headache |
4.0% |
| Hepatitis C |
4.0% |
| Hypertension |
4.0% |
| Insomnia |
3.5% |
| Prophylaxis |
3.2% |
| Pain |
3.0% |
| Type 2 Diabetes Mellitus |
2.5% |
| Rheumatoid Arthritis |
2.2% |
| Parkinson's Disease |
1.7% |
| Anxiety |
1.5% |
| Lipid Metabolism Disorder |
1.5% |
| Multiple Sclerosis |
1.5% |
| Schizoaffective Disorder |
1.5% |
| Bronchitis |
1.2% |
| Pulmonary Hypertension |
1.2% |
|
| Pyrexia |
7.8% |
| Hypotension |
5.9% |
| Laryngeal Oedema |
5.9% |
| Optic Ischaemic Neuropathy |
5.9% |
| Osteonecrosis |
5.9% |
| Transaminases Increased |
5.9% |
| Tremor |
5.9% |
| Vomiting |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| White Blood Cell Count Increased |
5.9% |
| Affective Disorder |
3.9% |
| Death |
3.9% |
| Fall |
3.9% |
| Hypercalcaemia |
3.9% |
| Hyperparathyroidism |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Migraine |
3.9% |
| Movement Disorder |
3.9% |
| Overdose |
3.9% |
| Pancreatitis Acute |
3.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.4% |
| Hypertension |
18.4% |
| Smoking Cessation Therapy |
18.4% |
| Headache |
16.3% |
| Pain |
14.3% |
| Product Used For Unknown Indication |
8.2% |
| Hypothyroidism |
4.1% |
|
| Heart Rate Decreased |
45.5% |
| Drug Interaction |
18.2% |
| Paraesthesia |
18.2% |
| Prinzmetal Angina |
9.1% |
| Somnolence |
9.1% |
|
